Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Small Cell Lung Carcinoma × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unresectable Pancreatic Cancer 1 Small Cell Lung Carcinoma 1 Liver, Cancer of, Non-Resectable 1 Colorectal Neoplasms 1 Advanced Intestinal Cancer 1 Advanced Gastric Cancer 1 Advanced Breast Cancer 1

Interventions

Drug Therapy 2 sintilimab 1 dinutuximab 1 atezolizumab 1 Topotecan 1 SR 48692 1 Rabeprazole 1 Irinotecan 1 Etoposide 1 Electroporation 1 EC regimen 1 E-3810 1 Cryosurgery 1 Carboplatin 1 Bevacizumab 1 2,2',4,4',5-pentachlorodiphenyl ether 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03239171 2019-01-25

Bioinformation Therapy for Lung Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡